Plasmapheresis in the treatment of myasthenia gravis: Retrospective study of 26 patients

Arquivos de Neuro-Psiquiatria

Volumn 62, Issue 2 B, 2004, Pages 391-395

  Carandina Maffeis, Rosana ^a   Nucci, Anamarli ^a   Marques Jr , José F C ^a   Roveri, Eduardo G ^a   Pfeilsticker, Beatriz H M ^a   Garibaldi, Solange G ^a   De Deus Silva, Leonardo ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Acceptance; Complications; Myasthenia gravis; Plasmapheresis; Therapeutics

Indexed keywords

AZATHIOPRINE; CHOLINESTERASE INHIBITOR; IMMUNOSUPPRESSIVE AGENT; PREDNISONE;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEATH; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; HUMAN; HYPOTENSION; INFECTION; MALE; MORTALITY; MYASTHENIA GRAVIS; ONSET AGE; PARESTHESIA; PLASMAPHERESIS; PREOPERATIVE TREATMENT; SCHOOL CHILD; THYMECTOMY; TREMOR;

EID: 3142740464     PISSN: 0004282X     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0004-282x2004000300003     Document Type: Article

References (26)

1. Drachaman DB. Myasthenia gravis. N Engl J Med 1994;330:1797-1807.
2. Strauss RG, Ciavarella D, Gilcher RO, et al. An overview of current management. J Clin Apheresis 1993;8:189-194.
3. Assessment of plasmapheresis. Report of the therapeutics and technology assessment subcommittee of the American Academy of Neurology. Neurology 1996;47:840-843.
4. Jaretzki A III, Barohn RJ, Ernstoff RM, et al. Myasthenia gravis: recommendations for clinical research standards. Neurology 2000;55:16-23.
5. Rodnitzky RL, Bosch EP. Chronic long-interval plasma exchange in myasthenia gravis. Arch Neurol 1984;41:715-717.
6. Komfeld P, Ambinder EP, Mittag T, et al. Plasmapheresis in refractory generalized myasthenia gravis. Arch Neurol 1981;38:478-481.
7. Sanders DB, Andrews IP, Howard JF, Massey JM. Seronegative myasthenia gravis. Neurology 1997:48(Suppl 5):S40-S45.
8. Newson-Davis J, Pinching AJ, Vincent A, Wilson SG. Function of circulating antibody to acetylcholine receptor in myasthenia gravis: investigation by plasma exchange. Neurology 1978;28:266-272.
9. Newson-Davis J, Vincent A, Wilson SG, Ward CD. Long-term effects of repeated plasma exchange in myasthenia gravis. Lancet 1979;1:464-468.
10. Behan PO, Shakir RA, Simpson JA, Burnett AK, Allan TL, Haase G. Plasma-exchange combined with immunosuppressive therapy in myasthenia gravis. Lancet 1979;1:438-440.
11. Carter B, Harrison R, Lunt GG, Behan PO, Simpson JA. Anti-acetylcholine receptor antibody titers in the sera of myasthenia patients treated with plasma exchange combined with immunosuppressive therapy. J Neurol Neurosurg Psychiatry 1980;43:397-402.
12. Dau PC, Lindstrom JM, Cassel CK, Denys EH, Shev EE, Spitler LE. Plasmapheresis and immunosuppressive drug therapy in myasthenia gravis. N Engl J Med 1977;297:1134-1140.
13. Osserman E, Genkins G. Studies in myasthenia gravis: review of a twenty-year experience in over 1200 patients. Mt Sinai J Med 1971;38:497-537.
14. Pinching AJ, Peters DK. Remission of myasthenia gravis following plasma exchange. Lancet 1976;2:1373-1376.
15. Clark WF, Rock GA, Buskard N et al. Therapeutic plasma exchange: an update from the Canadian Apheresis Group. Ann Intern Med 1999;131:453-462.
16. Yeh JH, Chiu H C. Therapeutic apheresis in Taiwan. Ther Apher 2001;5:513-516.
17. Seggia JCB, Abreu P, Takatani M. Plasmapheresis as preparatory method for thymectomy in myasthenia gravis. Arq Neuropsiquiatr 1995;53:411-415.
18. Dias-Tosta E, Fernandes RNM. Miastenia grave: tratamento com timectomia, corticóide e plasmaferese. Arq Neuropsiquiatr 1989;47:39-50.
19. Wendell S Neto, Assis JL, Marchiori PE. Métodos que removem anticorpos e células imunoagressivas: tratamento das crises miastênicas e colinérgicas. In Assis JL (Ed). Miastenia grave. São Paulo Sarvie,; 1990:253-263.
20. Werneck LC, Scola RH, Germiniani FMB, Comerlato EA, Cunha FMB. Myasthenic crisis: report of 24 cases. Arq Neuropsiquiatr 2002;60:519-524.
21. Spence PA, Morin JE, Katz M. Role of plasmapheresis in preparing myasthenic patients for thymectomy. Can J Surg 1984;27:303-304.
22. Empaire G, Hoaglin DC, Perlo VP, Pontoppidan H. Effect of prethymectomy plasma exchange on postoperative respiratory function in myasthenia gravis. J Thorac Cardiovasc Surg 1985;89:592-596.
23. Korach J M, Petitpas D, Paris B et al. Plasma exchange in France: epidemiology 2001. Tranfus Apheresis Sci 2003;29:153-157.
24. Kiprov DD, Golden P, Rohe R, Smith S, Hofmann J, Hunnicutt J. Adverse reactions associated with mobile therapeutic apheresis: analysis of 17,940 procedures. J Clin Apheresis 2001;16:130-133.
25. Shumak KH, Rock GA. Therapeutic plasma exchange. N Eng J Med 1984;310:762-771.
26. Lazo-Langener A, Espinosa-Poblano I, Tirado-Cardenas N et al. Therapeutic plasma exchange in Mexico: experience from a single institution. Am J Hematol 2002;70:16-21.